Refine by
Colorectal Cancer Equipment & Supplies
177 equipment items found
Manufactured by:Senti Biosciences based inSouth San Francisco, CALIFORNIA (USA)
Pursuing an Unmet Need in the Treatment of CRC - SENTI-401 is designed to more precisely target and eliminate colorectal cancer (CRC) cells while sparing healthy cells elsewhere in the body. Our vision is a potential medicine that more effectively treats patients with colorectal ...
Manufactured by:Polymedco, LLC based inCortlandt Manor, NEW YORK (USA)
OC-Auto FIT is a fecal immunochemical test (FIT) designed to enhance colorectal cancer screening by offering a highly accurate and clinically supported method. The test is geared towards individuals aged 45 to 75, adhering to Tier 1 guidelines, making it a critical tool in preventive healthcare. It boasts superior sensitivity and specificity, thereby effectively ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1700 is a stabilized recombinant version of Trefoil Factor 2 (TFF2) and is being developed by Tonix as a biologic to treat gastric and colorectal cancers. TFF2 is a small, secreted protein, encoded by the TFF2 gene in humans that is expressed in gastrointestinal mucosa where it functions to protect and repair mucosa. TFF2 is also expressed at low levels in ...
Manufactured by:Molecular Devices, LLC. based inSan Jose, CALIFORNIA (USA)
Derived from patient tissue our colorectal cancer organoids are available from a range of sites and TNM stages. They cover varied morphologies and growth ...
Manufactured by:Immunostics, Inc based inEatontown, NEW JERSEY (USA)
Greater sensitivity than traditional guaiac-based methods. Increased specificity to lower GI bleeding makes hema-screen SPECIFIC GOLD an ideal tool for colon cancer ...
Manufactured by:Innovatek Medical Inc. based inDelta, BRITISH COLUMBIA (CANADA)
Early detection of colorectal cancer is the key to successful ...
Manufactured by:HymonBio Co.,Ltd based inSuzhou, CHINA
HAEMOCERT Colorectal Cancer Screening Test has passed CE certification and is used for early colorectal cancer ...
Manufactured by:Hipro Biotechnology Co.,Ltd. based inShijiazhuang, CHINA
Zoan Fecal Occult Blood / Transferrin Combo Test Kit. Highlights:Early Bowel Cancer Screening, No pain & Non-invasive Detection, Fast Result in 5 Minutes, Home Test, Combined Test-2 result in 1 test, Easy operation with integrated design, Clean and Odourless, High accuracy&Specificity. Early screening of Colon Cancer can save millions of lives ...
Manufactured by:Epigenomics AG based inBerlin, GERMANY
Colorectal cancer is curable in about 90% of cases if detected early. Nevertheless, this disease is one of the most frequent causes of cancer-related deaths in the industrialized world. Regular screening can prevent colorectal cancer. Epi proColon® offers a convenient way of detecting ...
by:Carina Biotech based inMawson Lakes, AUSTRALIA
Advanced colorectal cancer currently has a poor prognosis and is the deadliest form of cancer for Australians 25 to 34 years old. LGR5 is a cancer stem cell marker that is highly expressed on advanced colorectal cancer and other cancers. In colon cancer patients, ...
Manufactured by:OncoDiag based inMiserey, FRANCE
An accurate blood-based test for the screening of colorectal cancer ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Detection Gene:KRAS,BRAF,NRAS,PIK3CA,TP53,DYPD,ERBB2,UGT1A1 and MSI（8 genes +MSI）. Detection Significance:Guiding individualized diagnosis and treatment of colorectal ...
Manufactured by:Hybribio based inKowloon Bay, HONG KONG
The Stool DNA Methylation Real-time PCR Kit serves as a diagnostic tool for individuals at high risk of colorectal cancer, facilitating in vitro qualitative detection of methylated SDC2 and TFPI2 genes within intestinal exfoliated cells. Designed for efficacy and user-friendliness, this kit enables easy operation while maintaining a short processing time without ...
Manufactured by:EntroGen, Inc. based inWoodland Hills, CALIFORNIA (USA)
The KRAS gene encodes a small GTPase that plays a key role in transducing signals from the epidermal growth factor receptor (EGFR) to downstream effectors. KRAS mutations have been commonly found in several types of human malignancies, such as metastatic colorectal cancer (mCRC), lung adenocarcinoma and thyroid cancer. The most common mutations ...
Manufactured by:EntroGen, Inc. based inWoodland Hills, CALIFORNIA (USA)
The KRAS gene encodes a small GTPase that plays a key role in transducing signals from the epidermal growth factor receptor (EGFR) to downstream effectors. KRAS mutations have been commonly found in several types of human malignancies, such as metastatic colorectal cancer (mCRC), lung adenocarcinoma and thyroid cancer. The most common mutations ...
by:Iterative Health, Inc. based inCambridge, MASSACHUSETTS (USA)
Accuracy is everything. Better adenoma detection can boost any GI practice’s standard of care. SKOUT uses advanced computer-vision technology to better recognize colorectal polyps. Gastroenterologists get real-time feedback during colonoscopies, making it easier to detect lesions early on. SKOUT augments but does not replace physician ...
Manufactured by:Taiho Oncology, Inc. based inPrinceton, NEW JERSEY (USA)
Colorectal cancer in combination with bevacizumab PHASE ...
Manufactured by:PREVENTIS GMBH based inBensheim, GERMANY
The immunological occult blood test PreventID® CC is a rapid test for self-testing for the qualitative detection of the valuable red blood pigment hemoglobin in stool as a marker for intestinal bleeding. The result can be read after 10 minutes. According to the WHO, colorectal cancer is the third most common cancer worldwide, with ...
by:Debiopharm based inLausanne, SWITZERLAND
It is the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®, which has dramatically changed the prognosis of colorectal cancer. In 1996, prior to the introduction of oxaliplatin, the standard of care for colorectal cancer was 5-fluorouracil (5-FU). Combination of oxaliplatin with 5-FU and ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
NRAS mutation is found in several cancers such as melanoma (13~25%), colorectal cancer (1~6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is know that the drug response against colorectal cancer medicine such as Erbitux and Cetuximab decreased ...